Recent Episodes
Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part I
Jacqueline C. Barrientos, MD, MS, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
CAR T-cell Therapy in 2022: What You Need to Know
Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA
Highpoints from Attending the 2021 American Society of Hematology Conference
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Updates on COVID-19 in Patients with Blood Cancer
John P. Leonard, MD, Weill Cornell Medicine, New York Presbyterian, New York, NY
A Conversation on Adult Survivorship
Maria Alma Rodriguez, MD, MACP, CMQ, The University of Texas MD Anderson Cancer Center, Houston, TX
The Advanced Practice Provider’s Role in Treating Newly Diagnosed Patients with Myeloma
Daniel Verina, DNP, ACNP-BC, Mount Sinai Medical Center, New York, NY
Categories
- All Episodes (69)
- CAR T-cell Therapy (8)
- Clinical Trials (3)
- COVID-19 (7)
- General Treatment & Support (17)
- Genomics (3)
- Health Equity (2)
- Leukemia (15)
- Lymphoma (9)
- Minimal Residual Disease (MRD) (2)
- Myelodysplastic Syndromes (2)
- Myeloma & Amyloidosis (9)
- Myeloproliferative Neoplasms (2)
- Pediatric and AYA (10)
- Rare Blood Cancers (3)
- Transplantation (1)
- Waldenström macroglobulinemia (2)
